Dick clark is no stranger to hard times. The chairman of Merck, a giant American drugs firm, got the top job after a safety scandal caused Vioxx, the firm's blockbuster painkiller, to be pulled from the market in 2004. The soft-spoken Mr Clark has won praise for his handling of that crisis and for being quicker than his rivals to start restructuring his firm in preparation for leaner years. He was also appointed head of Pharmaceutical Research and Manufacturers of America (PhRMA), the industry's lobbying arm.
展开▼
